Gumampong, Baby Boy .
HRN: 22-39-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/15/2023
01/22/2023
IV
170 Mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes